Genzyme Rejects Sanofi’s $18.5 Billion Offer

U.S. biotech company Genzyme Inc. (GENZ) rejected an $18.5 billion buyout offer from French drugmaker Sanofi-Aventis SA (SNY) on Monday, setting the stage for a protracted and potentially hostile takeover battle. – Reuters

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.